ForSight Robotics is an Israeli medical robotics company. Its core product is the JASPER™ Robotic Surgery Platform, designed for cataract surgery and broader ophthalmic procedures. It is not a traditional SaaS or enterprise software product, but rather a medical-device platform combining robotic hardware + software guidance + data analytics. Its goal is to augment ophthalmic surgeons with robotics and AI, helping address the global shortage of surgical eye-care resources.
Based on the information available on the website, JASPER™ emphasizes micron-level precision, 14 degrees of freedom, 3D image guidance and enhancement, real-time guidance, No-fly zones safety boundaries, surgical workflow data analytics, and an ergonomically neutral operating posture. These capabilities are aimed at solving common challenges in ophthalmic microsurgery, such as hand tremor, limited field of view, long learning curves, wide variation in surgical technique, and occupational strain on surgeons. Its reference to “actionable data” also suggests that the platform collects and analyzes surgical data to help improve techniques and standardize procedures.
The website does not disclose packages, pricing, purchasing models, maintenance fees, or consumables structure; it only provides a Request Demo option. News updates mention completed financing, the first fully robotic-assisted human cataract surgery, and ISO 13485:2016 certification, but do not clearly state the scope of regulatory approval, launch markets, or whether hospitals can currently purchase the system. As a result, potential customers evaluating budgets will need to contact the vendor directly to confirm equipment, service, training, and compliance costs.
Its strengths lie in a clearly defined use case and the massive demand for cataract surgery. The team and advisors bring relevant experience from companies such as Intuitive Surgical, Mazor Robotics, and Medtronic. Its technical direction is built around precision, safety, visualization, and standardization. The main weakness is that publicly available information remains largely brand- and vision-oriented, with limited details on clinical outcomes, cost-effectiveness, system integration, hospital IT connectivity, access control, API documentation, and other information typically required for enterprise procurement.
It is best suited to large ophthalmology hospitals, ophthalmic clinic chains, teaching hospitals, clinical research institutions, and medical groups looking to introduce robotic-assisted surgical capabilities. If you are simply looking for cloud-based enterprise software, remote collaboration tools, or general-purpose SaaS products, this platform is not a fit.
Website accessibility from mainland China is unknown, and payment methods are not disclosed. As a medical device, bringing it into China would also involve registration approval, clinical validation, after-sales maintenance, and local compliance requirements. Potential alternatives or complementary options include international ophthalmic device companies such as Alcon, ZEISS, and Johnson & Johnson Vision, as well as Chinese ophthalmic equipment and medical robotics companies.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on forsightrobotics.com official site.
forsightrobotics.com is an Israel SaaS Tools provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach forsightrobotics.com directly.